Adverse Drug Reaction Classification System

         

Pharmaceutical Information
Drug Name Procainamide
Drug ID BADD_D01842
Description A derivative of procaine with less CNS action.
Indications and Usage For the treatment of life-threatening ventricular arrhythmias.
Marketing Status approved
ATC Code C01BA02
DrugBank ID DB01035
KEGG ID D08421
MeSH ID D011342
PubChem ID 4913
TTD Drug ID D0U5SI
NDC Product Code Not Available
UNII L39WTC366D
Synonyms Procainamide | Procaine Amide | Amide, Procaine | Biocoryl | Novocainamide | Novocamid | Procainamide Hydrochloride | Hydrochloride, Procainamide | Procan | Procan SR | Procanbid | Pronestyl | Rhythmin | Apo-Procainamide | Procamide
Chemical Information
Molecular Formula C13H21N3O
CAS Registry Number 51-06-9
SMILES CCN(CC)CCNC(=O)C1=CC=C(C=C1)N
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice.
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Seizure17.12.03.001--
Shock24.06.02.002---
Supraventricular tachycardia02.03.03.012--
Swollen tongue07.14.02.003; 10.01.05.015; 23.04.01.014---
Synovitis15.04.02.001---
Systemic lupus erythematosus10.04.03.004; 15.06.02.003; 23.03.02.006---
Systemic lupus erythematosus rash10.04.03.005; 15.06.02.005; 23.03.13.007---
Thrombocytopenia01.08.01.002---
Tongue ulceration07.14.01.003---
Tremor17.01.06.002--
Urticaria10.01.06.001; 23.04.02.001--
Vasculitis10.02.02.006; 24.12.04.027--
Ventricular fibrillation02.03.04.008--
Ventricular tachycardia02.03.04.010--
Vomiting07.01.07.003--
Lupus-like syndrome10.04.03.003; 15.06.02.004; 23.03.02.004---
Musculoskeletal discomfort15.03.04.001---
Antinuclear antibody positive13.06.01.003---
Hepatic enzyme increased13.03.04.028---
Cardiac disorder02.11.01.003---
Electrocardiogram change13.14.05.014---
Decreased appetite08.01.09.028; 14.03.01.005--
Ill-defined disorder08.01.03.049---
Cardiac fibrillation02.03.02.021---
Psychotic disorder19.03.01.002--
Renal impairment20.01.03.010---
Gastrointestinal tract irritation07.08.03.008---
The 3th Page    First    Pre   3    Total 3 Pages
ADReCS-Target
Drug Name ADR Term Target
Tip:  Drug Name  ADR Term  Protein  Variation  Gene